CXCL10 and infection: To determine if IP-10 influences ZIKV replication, we treated prostate epithelial cells and stromal MSCs with 3.75 ng/mL recombinant human IP-10 three hours before, or 24 hours after infection with ZIKV-FLA or FLR at an MOI of 0.1.